New curative approach using embolization followed by moderate-dose radiotherapy after surgical failure for large right heart metastasis

por Delanian, Sylvie, Awad, Sameh, de Gramont, Aimery
Publicado 2021

Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes—An ESDO Report

por Van Cutsem, Eric, De Gramont, Aimery, Henning, Geoffrey, Rougier, Philippe, Bonnetain, Franck, Seufferlein, Thomas
Publicado 2017

MAINTENANCE HORMONAL TREATMENT IMPROVES PROGRESSION FREE SURVIVAL AFTER A FIRST LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST CANCER

por Dufresne, Armelle, Pivot, Xavier, Tournigand, Christophe, Facchini, Thomas, Alweeg, Thierry, Chaigneau, Loic, De Gramont, Aimery
Publicado 2008

Intrinsic bevacizumab resistance is associated with prolonged activation of autocrine VEGF signaling and hypoxia tolerance in colorectal cancer cells and can be overcome by ninteda...

por Mésange, Paul, Poindessous, Virginie, Sabbah, Michèle, Escargueil, Alexandre E., de Gramont, Aimery, Larsen, Annette K.
Publicado 2014

Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status

por Marijon, Hélène, Gery, Sigal, Chang, Hua, Landesman, Yosef, Shacham, Sharon, Lee, Dhong Hyun, de Gramont, Aimery, Koeffler, Harold Phillip
Publicado 2021

Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial

por Auclin, Edouard, André, Thierry, Taieb, Julien, Banzi, Maria, Van Laethem, Jean-Luc, Tabernero, Josep, Hickish, Tamas, de Gramont, Aimery, Vernerey, Dewi
Publicado 2019

Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOL...

por Hamidou, Zeinab, Chibaudel, Benoist, Hebbar, Mohamed, Hug de Larauze, Marine, André, Thierry, Louvet, Christophe, Brusquant, David, Garcia-Larnicol, Marie-Line, de Gramont, Aimery, Bonnetain, Franck
Publicado 2016

STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer

por Chibaudel, Benoist, Bonnetain, Franck, Tournigand, Christophe, de Larauze, Marine Hug, de Gramont, Armand, Laurent-Puig, Pierre, Paget, Jérôme, Hadengue, Alexandra, Notelet, Dominique, Benetkiewicz, Magdalena, André, Thierry, de Gramont, Aimery
Publicado 2015

Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study

por Diouf, Momar, Chibaudel, Benoist, Filleron, Thomas, Tournigand, Christophe, Hug de Larauze, Marine, Garcia-Larnicol, Marie-Line, Dumont, Sarah, Louvet, Christophe, Perez-Staub, Nathalie, Hadengue, Alexandra, de Gramont, Aimery, Bonnetain, Franck
Publicado 2014

ERCC1, XRCC1 and GSTP1 Single Nucleotide Polymorphisms and Survival of Patients with Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy

por Zaanan, Aziz, Dalban, Cécile, Emile, Jean-François, Blons, Hélène, Fléjou, Jean-François, Goumard, Claire, Istanbullu, Melek, Calmel, Claire, Alhazmi, Khalid, Validire, Pierre, Louvet, Christophe, de Gramont, Aimery, Laurent-Puig, Pierre, Taïeb, Julien, Praz, Françoise
Publicado 2014

FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer

por Carola, Candice, Ghiringhelli, François, Kim, Stefano, André, Thierry, Barlet, Juliette, Bengrine-Lefevre, Leïla, Marijon, Hélène, Garcia-Larnicol, Marie-Line, Borg, Christophe, Dainese, Linda, Steuer, Nils, Richa, Hubert, Benetkiewicz, Magdalena, Larsen, Annette K, de Gramont, Aimery, Chibaudel, Benoist
Publicado 2018

Bevacizumab-based first-line chemotherapy in elderly patients with metastatic colorectal cancer: an individual patient data based meta-analysis

por Koch, Christine, Schwing, Anna M., Herrmann, Eva, Borner, Markus, Diaz-Rubio, Eduardo, Dotan, Efrat, Feliu, Jaime, Okita, Natsuko, Souglakos, John, Arkenau, Hendrik T., Porschen, Rainer, Koopman, Miriam, Punt, Cornelis J.A., de Gramont, Aimery, Tournigand, Christophe, Zeuzem, Stefan, Trojan, Joerg
Publicado 2017

Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oroph...

por Chibaudel, Benoist, Lacave, Roger, Lefevre, Marine, Soussan, Patrick, Antoine, Martine, Périé, Sophie, Belloc, Jean-Baptiste, Banal, Alain, Albert, Sébastien, Chabolle, Frédéric, Céruse, Philippe, Baril, Philippe, Gatineau, Michel, Housset, Martin, Moukoko, Rachel, Benetkiewicz, Magdalena, de Gramont, Aimery, Bonnetain, Franck, Lacau St Guily, Jean
Publicado 2015

PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM‐398) or irinotecan with leucovorin/5‐fluorouracil as second‐line therapy in metastatic colorectal c...

por Chibaudel, Benoist, Maindrault‐Gœbel, Frédérique, Bachet, Jean‐Baptiste, Louvet, Christophe, Khalil, Ahmed, Dupuis, Olivier, Hammel, Pascal, Garcia, Marie‐Line, Bennamoun, Mostefa, Brusquant, David, Tournigand, Christophe, André, Thierry, Arbaud, Claire, Larsen, Annette K, Wang, Yi‐Wen, Yeh, C. Grace, Bonnetain, Franck, de Gramont, Aimery
Publicado 2016

Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the A...

por Chibaudel, Benoist, Henriques, Julie, Rakez, Manel, Brenner, Baruch, Kim, Tae Won, Martinez-Villacampa, Mercedes, Gallego-Plazas, Javier, Cervantes, Andres, Shim, Katharine, Jonker, Derek, Guerin-Meyer, Veronique, Mineur, Laurent, Banzi, Chiara, Dewdney, Alice, Dejthevaporn, Thitiya, Bloemendal, Haiko J., Roth, Arnaud, Moehler, Markus, Aranda, Enrique, Van Cutsem, Eric, Tabernero, Josep, Schmoll, Hans-Joachim, Hoff, Paulo M., André, Thierry, de Gramont, Aimery
Publicado 2020

Impact of Preoperative Chemotherapy Features on Patient Outcomes after Hepatectomy for Initially Unresectable Colorectal Cancer Liver Metastases: A LiverMetSurvey Analysis

por Innominato, Pasquale F., Cailliez, Valérie, Allard, Marc-Antoine, Lopez-Ben, Santiago, Ferrero, Alessandro, Marques, Hugo, Hubert, Catherine, Giuliante, Felice, Pereira, Fernando, Cugat, Esteban, Mirza, Darius F., Costa-Maia, Jose, Serrablo, Alejandro, Lapointe, Real, Dopazo, Cristina, Tralhao, Jose, Kaiser, Gernot, Chen, Jinn-Shiun, Garcia-Borobia, Francisco, Regimbeau, Jean-Marc, Skipenko, Oleg, Lin, Jen-Kou, Laurent, Christophe, Opocher, Enrico, Goto, Yuichi, Chibaudel, Benoist, de Gramont, Aimery, Adam, René
Publicado 2022

Evaluation of Continuous Tumor-Size–Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer

por Burzykowski, Tomasz, Coart, Elisabeth, Saad, Everardo D., Shi, Qian, Sommeijer, Dirkje W., Bokemeyer, Carsten, Díaz-Rubio, Eduardo, Douillard, Jean-Yves, Falcone, Alfredo, Fuchs, Charles S., Goldberg, Richard M., Hecht, J. Randolph, Hoff, Paulo M., Hurwitz, Herbert, Kabbinavar, Fairooz F., Koopman, Miriam, Maughan, Timothy S., Punt, Cornelis J. A., Saltz, Leonard, Schmoll, Hans-Joachim, Seymour, Matthew T., Tebbutt, Niall C., Tournigand, Christophe, Van Cutsem, Eric, de Gramont, Aimery, Zalcberg, John R., Buyse, Marc
Publicado 2019

Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis

por Yin, Jun, Dawood, Shaheenah, Cohen, Romain, Meyers, Jeff, Zalcberg, John, Yoshino, Takayuki, Seymour, Matthew, Maughan, Tim, Saltz, Leonard, Van Cutsem, Eric, Venook, Alan, Schmoll, Hans-Joachim, Goldberg, Richard, Hoff, Paulo, Hecht, J. Randolph, Hurwitz, Herbert, Punt, Cornelis, Diaz Rubio, Eduard, Koopman, Miriam, Cremolini, Chiara, Heinemann, Volker, Tournigard, Christophe, Bokemeyer, Carsten, Fuchs, Charles, Tebbutt, Niall, Souglakos, John, Doulliard, Jean-Yves, Kabbinavar, Fairooz, Chibaudel, Benoist, de Gramont, Aimery, Shi, Qian, Grothey, Axel, Adams, Richard
Publicado 2021

Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials

por McCleary, Nadine J, Harmsen, William S, Haakenstad, Ellana, Cleary, James M, Meyerhardt, Jeffrey A, Zalcberg, John, Adams, Richard, Grothey, Axel, Sobrero, Alberto F, Van Cutsem, Eric, Goldberg, Richard M, Peeters, Marc, Tabernero, Josep, Seymour, Matt, Saltz, Leonard B, Giantonio, Bruce J, Arnold, Dirk, Rothenberg, Mace L, Koopman, Miriam, Schmoll, Hans-Joachim, Pitot, Henry C, Hoff, Paulo M, Tebbutt, Niall, Masi, Gianluca, Souglakos, John, Bokemeyer, Carsten, Heinemann, Volker, Yoshino, Takayuki, Chibaudel, Benoist, deGramont, Aimery, Shi, Qian, Lichtman, Stuart M
Publicado 2022

Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database

por Ou, Fang-Shu, Ahn, Daniel H., Dixon, Jesse G., Grothey, Axel, Lou, Yiyue, Kasi, Pashtoon M., Hubbard, Joleen M., Van Cutsem, Eric, Saltz, Leonard B., Schmoll, Hans-Joachim, Goldberg, Richard M., Venook, Alan P., Hoff, Paulo, Douillard, Jean-Yves, Hecht, J. Randolph, Hurwitz, Herbert, Punt, Cornelis J. A., Koopman, Miriam, Bokemeyer, Carsten, Fuchs, Charles S., Diaz-Rubio, Eduardo, Tebbutt, Niall C., Cremolini, Chiara, Kabbinavar, Fairooz F., Bekaii-Saab, Tanios, Chibaudel, Benoist, Yoshino, Takayuki, Zalcberg, John, Adams, Richard A., de Gramont, Aimery, Shi, Qian
Publicado 2023